Many previous studies showed that LMP-1, LMP-2 has been considered as the molecular prognostic, diagnostic as well as the outcome of therapy in NPC (Hao et al., 2004; Hariwiyanto et al., 2010; Rosales-Pérez et al., 2014; Lao et al., 2017). Here, PSMB9 is linked to nasopharyngeal carcinoma.